Finance Home - My Yahoo - Yahoo! - Help

Tuesday, December 22, 2009, 10:23AM ET - U.S. Markets close in 5 hours and 37 minutes. Dow  0.61% Nasdaq  0.63%

Hana Biosciences, Inc. (HNAB.OB)

At 10:03AM ET: 0.18   0.00 (0.00%)

MORE ON HNAB.OB

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Wed, Dec 16, 2009 • Hana Biosciences Appoints Howard Furst, M.D., M.B.A., to Board of Directors GlobeNewswire (Wed, Dec 16) Tue, Dec 15, 2009 • Hana Bio names Deerfield exec to board at bizjournals.com (Tue, Dec 15) • HANA BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online (Tue, Dec 15) Tue, Dec 8, 2009 • HANA BIOSCIENCES INC Financials EDGAR Online Financials (Tue, Dec 8) • HANA BIOSCIENCES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Tue, Dec 8) Mon, Dec 7, 2009 • Hana Biosciences Announces Positive Data From Pivotal rALLy Clinical Trial of Marqibo(R) in Acute Lymphoblastic Leukemia at 51st American Society of Hematology Annual Meeting GlobeNewswire (Mon, Dec 7) Wed, Dec 2, 2009 • Hana Biosciences Completes Enrollment in Pivotal Phase 2 rALLy Clinical Trial of Marqibo(R) in Acute Lymphoblastic Leukemia GlobeNewswire (Wed, Dec 2) Tue, Dec 1, 2009 • Hana Biosciences to Present Data From Pivotal rALLy Clinical Trial of Marqibo(R) in Acute Lymphoblastic Leukemia GlobeNewswire (Tue, Dec 1) Tue, Nov 24, 2009 • Hana Biosciences to Present at the 21st Annual Piper Jaffray Healthcare Conference GlobeNewswire (Tue, Nov 24) Fri, Nov 13, 2009 • Hana Biosciences Announces Third Quarter 2009 Results GlobeNewswire (Fri, Nov 13) Thu, Nov 12, 2009 • HANA BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Thu, Nov 12) Thu, Nov 5, 2009 • HANA BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online (Thu, Nov 5) Thu, Oct 22, 2009 • Hana Biosciences to Present at the 8th Annual BIO Investor Forum GlobeNewswire (Thu, Oct 22) Fri, Oct 9, 2009 • HANA BIOSCIENCES INC Files SEC form 8-K, Other Events EDGAR Online (Fri, Oct 9) Thu, Oct 8, 2009 • Hana Biosciences Completes $12.4 Million Private Placement GlobeNewswire (Thu, Oct 8) • HANA BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secu EDGAR Online (Thu, Oct 8) • Hana Biosciences Announces $12.4 Million Private Placement GlobeNewswire (Thu, Oct 8) Wed, Sep 30, 2009 • Hana Biosciences Enters Into Clinical Trial Agreement With the National Cancer Institute for Development of Marqibo(R) in Pediatric Cancer GlobeNewswire (Wed, Sep 30) Sat, Sep 12, 2009 • HANA BIOSCIENCES INC Financials EDGAR Online Financials (Sat, Sep 12) Thu, Sep 10, 2009 • HANA BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial O EDGAR Online (Thu, Sep 10) Older Headlines - Download Recent Headlines View headlines from: Thu, Sep 10, 2009Thu, Sep 3, 2009Thu, Aug 27, 2009Thu, Aug 20, 2009Thu, Aug 13, 2009Thu, Aug 6, 2009Thu, Jul 30, 2009Thu, Jul 23, 2009Thu, Jul 16, 2009Thu, Jul 9, 2009 Add HNAB.OB News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage